Your browser doesn't support javascript.
loading
Myxedema Secondary to Levothyroxine Malabsorption in Newly Diagnosed Celiac Disease.
Wiggins, Brandon; Knight, Kyle T; Banno, Fady; Minaudo, Mark.
Affiliation
  • Wiggins B; Internal Medicine, Ascension Genesys Hospital, Grand Blanc, USA.
  • Knight KT; Internal Medicine, Ascension Health, Grand Blanc, USA.
  • Banno F; Internal Medicine, Ascension Health, Grand Blanc, USA.
  • Minaudo M; Gastroenterology and Hepatology, Ascension Health, Grand Blanc, USA.
Cureus ; 14(5): e25491, 2022 May.
Article in En | MEDLINE | ID: mdl-35783876
ABSTRACT
Celiac disease (CD) is an autoimmune disorder that predominantly affects the small intestine and is related to antibodies created against gluten when the substance is ingested. It is uncommon comorbidity in patients with Hashimoto's thyroiditis (HT). Myxedema is a severe form of hypothyroidism that is commonly related to new diagnoses, medication non-compliance, or malabsorption of thyroid supplementation that can have life-threatening associated conditions like heart failure and coma. In this article, we will describe a case of myxedema secondary to levothyroxine malabsorption in the setting of a newly diagnosed CD.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Diagnostic_studies Language: En Journal: Cureus Year: 2022 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Diagnostic_studies Language: En Journal: Cureus Year: 2022 Document type: Article Affiliation country: